These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Guidelines for treatment of anthrax. Meyerhoff A; Murphy D JAMA; 2002 Oct; 288(15):1848-9; author reply 1848-9. PubMed ID: 12377082 [No Abstract] [Full Text] [Related]
8. Anthrax prevention and treatment. FDA Consum; 2001; 35(6):9. PubMed ID: 11785495 [No Abstract] [Full Text] [Related]
9. Overlooked in Cipro hype: other anti-anthrax meds. Diamond F Manag Care; 2001 Nov; 10(11):37-8. PubMed ID: 11761591 [No Abstract] [Full Text] [Related]
10. Obiltoxaximab (Anthim) for inhalation anthrax. Med Lett Drugs Ther; 2018 Sep; 60(1555):150-151. PubMed ID: 30383733 [No Abstract] [Full Text] [Related]
11. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472 [TBL] [Abstract][Full Text] [Related]
12. Obiltoxaximab: First Global Approval. Greig SL Drugs; 2016 May; 76(7):823-30. PubMed ID: 27085536 [TBL] [Abstract][Full Text] [Related]
13. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150 [TBL] [Abstract][Full Text] [Related]
14. Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule. Nagy CF; Mondick J; Serbina N; Casey LS; Carpenter SE; French J; Guttendorf R Clin Transl Sci; 2017 Jan; 10(1):12-19. PubMed ID: 27925405 [TBL] [Abstract][Full Text] [Related]
15. Fast tracking drugs to patients. Drug approval agencies are frequently criticised for either being too slow or too fast. Brower V EMBO Rep; 2002 Jan; 3(1):14-6. PubMed ID: 11799053 [No Abstract] [Full Text] [Related]
16. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925 [TBL] [Abstract][Full Text] [Related]
17. US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax. Meyerhoff A; Albrecht R; Meyer JM; Dionne P; Higgins K; Murphy D Clin Infect Dis; 2004 Aug; 39(3):303-8. PubMed ID: 15306995 [TBL] [Abstract][Full Text] [Related]
19. Anthrax drug first antibacterial mAb to win approval. Fox JL Nat Biotechnol; 2013 Jan; 31(1):8. PubMed ID: 23302914 [No Abstract] [Full Text] [Related]
20. Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax. Migone TS; Bolmer S; Zhong J; Corey A; Vasconcelos D; Buccellato M; Meister G Antimicrob Agents Chemother; 2015 Feb; 59(2):1145-51. PubMed ID: 25487792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]